• For Institutions

    • Corporate Services
    • Developers
  • Download
  • Help
  • About

    • Company Profile
    • License & Regulatory
    • Media coverage
longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
All
Options & Futures
Funds
IPO Subscription
Structured Products
Investment Wiki
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List

ProQR Therap(PRQR.US)

Overview
News
Financials
© 2026 Longbridge|Disclaimer

Event Tracking

Nov7
ProQR Therapeutics released FY2025 9 Months Earnings on November 6 (EST), actual revenue USD 13.2 M, actual EPS USD -0.3712
04:00
ProQR Therapeutics released FY2025 Q3 earnings on November 6 (EST), actual revenue USD 3.419 M (forecast USD 7.034 M), actual EPS USD -0.1225 (forecast USD -0.1197)
04:00
Nov5
Analyst Maintains Buy Rating on ProQR Stock
06:22
Oct15
Wolleben's Stock Recommendations Success Rate and Return Rate
13:12
Oct13
ProQR Therapeutics NV to Attend Chardan's 9th Annual Gene Therapy Conference
12:30
Oct1
ProQR Therapeutics stock price breaks above 50-day moving average
09:28

Schedules & Filings

Schedules
Filings
Nov6
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 3.419 M, Net Income -12.91 M, EPS -0.1225

Aug7
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 4.653 M, Net Income -14.26 M, EPS -0.1404

May8
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 5.132 M, Net Income -10.91 M, EPS -0.1082

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
INBS
9.530
+132.44%
+5.430
ANGH
3.770
+62.50%
+1.450
WTO
1.020
+61.09%
+0.387
ESHAR
0.2500
+47.06%
+0.080
NCL
0.2731
+40.77%
+0.079
FGMCR
0.5500
+33.50%
+0.138
ESHA
19.180
+33.38%
+4.800
IPEXR
0.8000
+31.97%
+0.194
RDACR
0.2400
+26.32%
+0.050
DVLT
0.6521
+26.25%
+0.136
View More